Rivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease: A Post Hoc Secondary Analysis of the AFIRE Trial.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2022.1561
Abstract: Importance Appropriate regimens of antithrombotic therapy for patients with atrial fibrillation (AF) and coronary artery disease (CAD) have not yet been established. Objective To compare the total number of thrombotic and/or bleeding events between rivaroxaban… read more here.
Keywords: rivaroxaban monotherapy; therapy; monotherapy; combination therapy ... See more keywords
TCT-866 Association of Age With the Risk of Thrombotic and Bleeding Event After Percutaneous Coronary Intervention
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.08.2117
Abstract: Elderly are regarded as high bleeding risk patients. But the association of age with thrombotic or bleeding events after percutaneous coronary intervention (PCI) has not been sufficiently analyzed so far. Among total 19,489 patients in… read more here.
Keywords: risk; association age; thrombotic bleeding; bleeding ... See more keywords